Application of Quality by Design in Ophthalmic Nano Formulations

dc.contributor.guide	Mahajan, S S
dc.coverage.spatial	Pharmaceutics
dc.creator.researcher	Pujari, Sapna R
dc.date.accessioned	2022-08-05T05:44:10Z
dc.date.available	2022-08-05T05:44:10Z
dc.date.awarded	2021
dc.date.completed	2021
dc.date.registered	2015
dc.description.abstract	None newline
dc.description.note
dc.format.accompanyingmaterial	CD
dc.format.dimensions
dc.format.extent
dc.identifier.uri	http://hdl.handle.net/10603/397592
dc.language	English
dc.publisher.institution	C U Shah College of Pharmacy
dc.publisher.place	Mumbai
dc.publisher.university	SNDT Womens University
dc.relation	xxxii,783
dc.rights	university
dc.source.university	University
dc.subject.keyword	Brinzolamide ophthalmic nanosuspension
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	glaucoma
dc.subject.keyword	nanotechnology
dc.subject.keyword	ophthalmic drug delivery system
dc.subject.keyword	travoprost ophthalmic solution
dc.title	Application of Quality by Design in Ophthalmic Nano Formulations
dc.title.alternative
dc.type.degree	Ph.D.